Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports a material fact notice dated October 30, 2024. The filing details a new share buyback program approved by the Board of Directors, effective immediately following the conclusion of a prior program.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures for the period. The primary financial data points disclosed are:
- Outstanding Shares: 4,388,851,573 common shares (as defined in CVM Resolution 77/2022).
- Buyback Limit: Up to 155,159,038 common shares.
- Accounting Treatment: Acquisitions will be recorded as a debit on the capital reserve in the balance sheet dated as of September 30, 2024.
Material Changes
The Board of Directors approved a new share repurchase program to replace the previous program approved in May 2024, which ended upon reaching its repurchase limit. The new program authorizes the repurchase of up to 155,159,038 shares with the primary purpose of cancellation. Shares not canceled may be held in treasury or used for share-based compensation plans.
Guidance, Outlook, and Risks
Program Duration: The buyback program is effective until April 30, 2026.
Execution: Transactions will be executed through designated brokers including UBS Brasil, Merrill Lynch S.A., Santander Corretora, and Itaú Corretora.
Risks/Contingencies: The filing does not explicitly list new risks or contingencies beyond the standard execution of the buyback program.
Investor Verification Checklist
- Verify the exact number of shares repurchased under the new program via subsequent disclosures.
- Confirm the impact of the buyback on the capital reserve and total equity in the next quarterly report.
- Monitor the utilization of treasury shares for share-based compensation plans versus cancellation.
- Review the full "Notice Regarding the Negotiation of Shares Issued by the Company" referenced as Exhibit G for detailed trading parameters.